|
Dear Grants Officer:
The American Cancer Society announces this revised Request for Applications for the American Cancer Society MEN2 Thyroid Cancer Consortium. Up to seven (7) Research Scholar and/or Mentored Research Scholar grants and up to five (5) Postdoctoral Fellow grants will be awarded. The Consortium will be led by a single renowned senior scientist who will be awarded the American Cancer Society MEN2 Thyroid Cancer Professorship and act as leader for the overall program (details at links below). Appropriate areas of investigation include, but are not limited to: understanding consequences of RET mutations, molecular events underlying the development of MEN2-related tumors, improved animal models of MEN2, new screening and monitoring tools, new imaging approaches, and new pharmacologic and other strategies to blunt the effects of mutations in RET and other genes associated with medullary thyroid cancer.
Individuals applying for a Research Scholar Grant must have an independent research or faculty position and can be at any stage of their career. These grants will be awarded for up to $200,000 a year, direct costs, for 5 years. Mentored Research Scholar Grants will be awarded to junior faculty members with a doctoral degree in a clinical or cancer control research discipline (e.g., M.D., and/or Ph.D.) that are within the first four years of a full time faculty appointment or equivalent, and have no more than 4 years of postdoctoral research experience immediately prior to their faculty appointment. The successful applicant is expected to transition into a career as an independent investigator. Awards are for up to five years and for up to $135,000 per year direct costs.
Applicants for Postdoctoral Fellowships must have obtained their doctoral degree prior to activation of the fellowship. Awards are for three years with progressive stipends of $44,000, $46,000, and $48,000 per year, plus a $4,000 per year fellowship allowance. Individuals who have held a PhD or MD for more than 4 years at the time of application are not eligible.
Deadline: Complete applications are due by April 1, 2010. Funding will begin January 1, 2011. For information regarding funding policies or to obtain an application, go to https://proposalcentral.altum.com or refer to the ACS website at www.cancer.org/research: select Funding Opportunities followed by Index of Grants, scroll down to Special Initiatives and select the appropriate RFA for MEN2 Thyroid Cancer.
Sincerely,
Charles Saxe, PhD
Scientific Program Director
(404) 929-6919
Charles.Saxe@cancer.org
|
|
 |
Home | About Us | Legal
& Privacy Information | State
Fundraising Notices
For more information on the American Cancer Society, visit us at cancer.org.
This email was sent to kjanowski@asgt.org.
If this email was an inconvenience to
you, we apologize.
If you would like to opt out of Grantee emails in the future, click here.
Please note, you will continue to receive other American Cancer Society communications.
If you would like to let us know about all of your communication preferences, click here.
The American Cancer Society | National Home Office |
250 Williams Street NW| Atlanta, GA 30303-1002
Copyright 2000-2010 ©
American Cancer Society
|
|
|
